Skip to content
Nonprofiteer
← INTERNATIONAL AIDS VACCINE INITIATIVE INC

Form 990 for tax year 2024

Filed by INTERNATIONAL AIDS VACCINE INITIATIVE INC.

Totals

Total revenue
$131,181,475
Total expenses
$143,043,595
Contributions and grants received
$126,009,254
Grants paid
$33,692,633
Program service revenue
$2,511,798
Investment income
$2,295,284
Other revenue
$365,139
Total assets, end of year
$129,852,638
Total liabilities, end of year
$78,459,588
Net assets or fund balances, end of year
$51,393,050
Program services expenses (Part IX)
$127,097,658
Management and general expenses
$15,722,342
Fundraising expenses
$223,595
Program service expenses (Part III)
$127,097,658

Program services were 88.9% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1d · Related organizations

    $114,881

  • 1e · Government grants (contributions)

    $65,643,855

  • 1f · All other contributions, gifts and grants

    $60,250,518

  • 2a · Program service revenue: CONTRACT SERVICE FEES

    total $1,896,798 · related or exempt $1,896,798

  • 2b · Program service revenue: RESEARCH & DEVELOPMENT

    total $615,000 · related or exempt $615,000

  • 3 · Investment income

    total $2,365,037 · excluded $2,365,037

  • 7a · Gross sales of assets other than inventory

    securities $7,951,143

  • 7b · Less cost or other basis and sales expenses

    securities $8,020,896

  • 7c · Gain or loss

    securities -$69,753

  • 7d · Net gain or loss

    total -$69,753 · excluded -$69,753

  • 11a · Other revenue: DATA DEF. BUILD OUT

    total $150,000 · excluded $150,000

  • 11b · Other revenue: PROPERTY REASSESS.

    total $128,245 · excluded $128,245

  • 11c · Other revenue: MISCELLANEOUS

    total $86,894 · excluded $86,894

  • 11e · Other revenue, total

    $365,139

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $7,951,405 · program services $7,951,405

  • 3 · Grants to foreign organizations and individuals

    total $25,741,228 · program services $25,741,228

  • 5 · Compensation of officers, directors and key employees

    total $2,984,897 · program services $182,329 · management and general $2,802,568

  • 7 · Other salaries and wages

    total $37,714,276 · program services $28,906,033 · management and general $8,788,918 · fundraising $19,325

  • 8 · Pension plan contributions

    total $3,378,540 · program services $3,378,540

  • 9 · Other employee benefits

    total $3,942,069 · program services $3,877,629 · management and general $64,440

  • 10 · Payroll taxes

    total $2,819,004 · program services $2,819,004

  • 11b · Fees: legal

    total $545,941 · program services $146,199 · management and general $399,742

  • 11c · Fees: accounting

    total $201,935 · management and general $201,935

  • 11d · Fees: lobbying

    total $180,000 · fundraising $180,000

  • 11f · Fees: investment management

    total $75,428 · management and general $75,428

  • 11g · Fees: other

    total $1,068,244 · program services $106,489 · management and general $961,755

  • 13 · Office expenses

    total $1,104,638 · program services $737,670 · management and general $366,968

  • 14 · Information technology

    total $2,110,758 · program services $1,625,717 · management and general $485,041

  • 16 · Occupancy

    total $4,454,015 · program services $4,017,180 · management and general $436,835

  • 17 · Travel

    total $2,187,165 · program services $1,853,259 · management and general $329,461 · fundraising $4,445

  • 22 · Depreciation, depletion and amortization

    total $581,763 · program services $535,859 · management and general $45,904

  • 23 · Insurance

    total $465,337 · program services $329,698 · management and general $135,639

  • 24a · Other expenses: RESEARCH&CLINICAL SVCS

    total $39,380,479 · program services $38,907,146 · management and general $473,333

  • 24b · Other expenses: LAB SUPPLIES/EQUIPMENT

    total $4,779,891 · program services $4,779,891

  • 24c · Other expenses: EQUIPMENT MAINT.

    total $824,274 · program services $801,517 · management and general $22,757

  • 24d · Other expenses: OFFICE FURNITURE

    total $288,378 · program services $288,378

  • 24e · All other expenses

    total $263,930 · program services $112,487 · management and general $131,618 · fundraising $19,825

Balance sheet

Part X, book values.

  • 2 · Savings and temporary cash investments

    beginning of year $34,403,229 · end of year $18,632,887

  • 3 · Pledges and grants receivable

    beginning of year $46,434,558 · end of year $43,074,450

  • 4 · Accounts receivable

    beginning of year $279,535 · end of year $219,130

  • 9 · Prepaid expenses and deferred charges

    beginning of year $146,763 · end of year $241,274

  • 10a · Land, buildings and equipment: cost or other basis

    $48,104,225

  • 10b · Land, buildings and equipment: accumulated depreciation

    $47,263,032

  • 10c · Land, buildings and equipment, net

    beginning of year $927,381 · end of year $841,193

  • 11 · Investments: publicly traded securities

    beginning of year $33,407,409 · end of year $36,526,217

  • 15 · Other assets

    beginning of year $8,635,068 · end of year $30,317,487

  • 17 · Accounts payable and accrued expenses

    beginning of year $9,420,265 · end of year $7,911,112

  • 18 · Grants payable

    beginning of year $11,781,746 · end of year $9,292,944

  • 19 · Deferred revenue

    beginning of year $28,968,880 · end of year $31,126,467

  • 25 · Other liabilities

    beginning of year $10,139,300 · end of year $30,129,065

  • 27 · Net assets without donor restrictions

    beginning of year $32,056,013 · end of year $27,604,225

  • 28 · Net assets with donor restrictions

    beginning of year $31,867,739 · end of year $23,788,825

Mission and programs · 2024

Mission

A NONPROFIT SCIENTIFIC RESEARCH ORGANIZATION THAT DEVELOPS VACCINES AND ANTIBODIES FOR HIV, TUBERCULOSIS, AND EMERGING INFECTIOUS DISEASES.

Activities or mission (Part I)

TRANSLATE SCIENTIFIC DISCOVERIES INTO AFFORDABLE, GLOBALLY ACCESSIBLE PUBLIC HEALTH SOLUTIONS

  • RESEARCH AND DEVELOPMENT: THROUGH SCIENTIFIC AND CLINICAL RESEARCH IN AFRICA, INDIA, EUROPE, AND THE U.S., IAVI DEVELOPS VACCINES AND ANTIBODIES IN AND FOR THE DEVELOPING WORLD AND SEEKS TO ACCELERATE THEIR INTRODUCTION IN LOW-INCOME COUNTRIES. IAVI ADVANCES SCIENTIFIC DISCOVERY AND DEVELOPMENT BY FOSTERING UNIQUE COLLABORATIONS AMONG ACADEMIA, INDUSTRY, LOCAL COMMUNITIES, GOVERNMENTS, AND FUNDERS TO EXPLORE NEW AND BETTER WAYS TO ADDRESS PUBLIC HEALTH THREATS THAT DISPROPORTIONATELY AFFECT PEOPLE LIVING IN POVERTY. VACCINE AND ANTIBODY CANDIDATES ARE PUT THROUGH A RIGOROUS PROCESS OF CLINICAL EVALUATION AMONG KEY POPULATIONS TO ESTABLISH THEIR SAFETY AND EFFICACY, AN EFFORT THAT ENABLES IAVI TO STRENGTHEN THE HEALTHCARE INFRASTRUCTURE AND SCIENTIFIC CAPACITY OF COUNTRIES WHERE OUR CLINICAL PARTNERS OPERATE. TO DATE, IAVI AND ITS PARTNERS HAVE ADVANCED DOZENS OF HIV VACCINE CANDIDATES INTO EARLY-STAGE CLINICAL TRIALS, INCLUDING A VACCINE CANDIDATE THAT HAS YIELDED PROMISING EARLY RESULTS AND IS PART OF AN EXCITING NEW APPROACH TO HIV VACCINE DESIGN. OTHER NOTABLE ACHIEVEMENTS INCLUDE THE FIRST HIV VACCINE TRIALS IN SUB-SAHARAN COUNTRIES, WHERE HIV BURDEN IS GREATEST, AND THE FIRST TRIAL OF AN MRNA HIV VACCINE CANDIDATE IN AFRICA. IAVI HAS CONDUCTED MORE THAN 50 EPIDEMIOLOGICAL STUDIES AND PROVIDED VOLUNTARY HIV TESTING, COUNSELING SERVICES, AND HEALTH CARE REFERRALS TO MORE THAN 870,000 INDIVIDUALS IN AFRICA. IAVI ALSO SUPPORTS PRECLINICAL DEVELOPMENT AND CLINICAL TESTING OF VACCINE CANDIDATES FOR OTHER DISEASES, INCLUDING TUBERCULOSIS, LASSA FEVER, MARBURG, AND EBOLA SUDAN, AS WELL AS ANTIBODY CANDIDATES FOR DISEASE PREVENTION AND TREATMENT. IAVI CONDUCTS TRIALS WITH THE HIGHEST SCIENTIFIC AND ETHICAL STANDARDS TO PROTECT THE RIGHTS, WELL-BEING, AND DIGNITY OF TRIAL VOLUNTEERS. IAVI HAS ALSO LAUNCHED RESEARCH CONSORTIA TO ADDRESS MAJOR SCIENTIFIC PROBLEMS OF BIOMEDICAL PRODUCT DEVELOPMENT. A SIGNIFICANT PORTION OF RESEARCH IAVI SUPPORTS IS CONDUCTED IN LOW-INCOME COUNTRIES WHERE THE NEED FOR INFECTIOUS DISEASE PREVENTION IS GREATEST. IAVI ALSO SUPPORTS EXTERNAL RESEARCHERS BY PROVIDING TECHNICAL AND SCIENTIFIC EXPERTISE TO ACCELERATE THE DEVELOPMENT OF THEIR OWN PRODUCTS.

    Expenses $127,097,658 · Grants $33,692,633 · Revenue $2,511,798

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Mark B Feinberg

    PRESIDENT/CEO

    Total calculated
    $784,374
    From this org
    $718,500
    From related orgs
    $0
    Other
    $65,874
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $594,776
    Bonus
    $62,382
    Other
    $61,342
    Deferred
    $65,182
    Nontaxable benefits
    $692
    Filer's total
    $784,374

  • Eric Paul Goosby

    BOARD CHAIR

    Total calculated
    $0
    Hours/week
    2

  • Robert Goldberg

    BOARD TREASURER

    Total calculated
    $0
    Hours/week
    2

  • Linda-Gail Becker

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • David Blumberg

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Jim Connolly

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Mark Dybul

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Wafaa El-Sadr

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Alexis M Pinto

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • John W Shiver

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Susan Silbermann

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Anne Martin Simonds

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Rajeev Venkayya

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Marijke Wijnroks

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1

  • Ana Cespedes Montoya

    CHIEF OPERATING OFFICER

    Total calculated
    $614,134
    From this org
    $552,506
    From related orgs
    $0
    Other
    $61,628
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $456,945
    Bonus
    $44,647
    Other
    $50,914
    Deferred
    $38,250
    Nontaxable benefits
    $23,378
    Filer's total
    $614,134

  • Mario Gagliano

    CHIEF PEOPLE OFFICER, VP OF HR

    Total calculated
    $445,185
    From this org
    $364,310
    From related orgs
    $0
    Other
    $80,875
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $336,672
    Bonus
    $24,644
    Other
    $2,994
    Deferred
    $31,625
    Nontaxable benefits
    $49,250
    Filer's total
    $445,185

  • Min Ding

    GENERAL COUNSEL/BOARD SECRETARY

    Total calculated
    $441,018
    From this org
    $368,570
    From related orgs
    $0
    Other
    $72,448
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $306,375
    Bonus
    $29,201
    Other
    $32,994
    Deferred
    $37,667
    Nontaxable benefits
    $34,781
    Filer's total
    $441,018

  • Louis D Schwartz

    ASST. SEC., CHIEF FIN. & ADMIN OFF.

    Total calculated
    $422,106
    From this org
    $353,545
    From related orgs
    $0
    Other
    $68,561
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $293,701
    Bonus
    $25,688
    Other
    $34,156
    Deferred
    $33,780
    Nontaxable benefits
    $34,781
    Filer's total
    $422,106

  • Brandon Saft

    DEPUTY CHIEF FINANCIAL OFFICER

    Total calculated
    $278,078
    From this org
    $255,811
    From related orgs
    $0
    Other
    $22,267
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $217,613
    Bonus
    $10,000
    Other
    $28,198
    Deferred
    $12,808
    Nontaxable benefits
    $9,459
    Filer's total
    $278,078

  • Swati Gupta

    VP, HEAD OF EID AND EPIDEMIOLOGY

    Total calculated
    $470,736
    From this org
    $402,341
    From related orgs
    $0
    Other
    $68,395
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $336,711
    Bonus
    $33,216
    Other
    $32,414
    Deferred
    $38,250
    Nontaxable benefits
    $30,145
    Filer's total
    $470,736

  • Christopher Parks

    ASS. VP, VIRAL VACC. & HEAD OF DDL

    Total calculated
    $452,087
    From this org
    $380,753
    From related orgs
    $0
    Other
    $71,334
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $315,208
    Bonus
    $30,809
    Other
    $34,736
    Deferred
    $38,250
    Nontaxable benefits
    $33,084
    Filer's total
    $452,087

  • Dagna Laufer

    VP AND HEAD OF CLINICAL DEVELOPMENT

    Total calculated
    $441,786
    From this org
    $402,844
    From related orgs
    $0
    Other
    $38,942
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $339,864
    Bonus
    $24,950
    Other
    $38,030
    Deferred
    $38,250
    Nontaxable benefits
    $692
    Filer's total
    $441,786

  • Marion Gruber

    VP, PUBLIC HEALTH & REG. SCIENCE

    Total calculated
    $422,077
    From this org
    $383,236
    From related orgs
    $0
    Other
    $38,841
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $330,252
    Bonus
    $30,712
    Other
    $22,272
    Deferred
    $38,841
    Nontaxable benefits
    $0
    Filer's total
    $422,077

  • Sangeetha Sagar

    VICE PRESIDENT, PDC

    Total calculated
    $419,843
    From this org
    $384,858
    From related orgs
    $0
    Other
    $34,985
    Hours/week
    35

    Schedule J breakdown matched by us

    Base
    $352,921
    Bonus
    $25,726
    Other
    $6,211
    Deferred
    $34,985
    Nontaxable benefits
    $0
    Filer's total
    $419,843

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 7 · Other non-fixed payments

Answered no

  • 4a · Severance or change-of-control payment
  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 7
MERIT-BASED BONUS COMPENSATION HAS BEEN REFLECTED IN PART II, COLUMN (B)(II).

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

The 10 largest by cash amount. The API serves every itemized grant.

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

  • STICHTING IAVI

    N/A · RESEARCH SUPPORT · NL · controlled entity

    Directly controlled by IAVI INC

  • IAVI INDIA

    N/A · RESEARCH SUPPORT · IN · controlled entity

    Directly controlled by IAVI INC

  • IAVI SOUTH AFRICA NPC (IAVI-SA)

    N/A · RESEARCH SUPPORT · SF · controlled entity

    Directly controlled by IAVI INC

  • IAVI AFRICA LIMITED

    N/A · RESEARCH SUPPORT · KE · controlled entity

    Directly controlled by IAVI INC

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Disregarded entities

Part I: entities that legally are the filer and file no return of their own.

  • IAVI LAB LLC

    LAB RESEARCH · DE · income $0 · assets $0

    Directly controlled by IAVI INC

  • IAVI GLOBAL HEALTH IMPACT LLC

    FACILITATE PRODUCT DEVELOPMENT AND/OR COMMERCIALIZATION · DE · income $0 · assets $0

    Directly controlled by IAVI INC

Provenance

Return type
form_990
Tax year
2024
Filed
30 October 2025
IRS schema version
2024v5.2
Source object
202523039349302807

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.